openPR Logo
Press release

High Demand Drives Global Drug Eluting Balloon Catheter Market Progress through 2017-2022 | Key Players are Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corpora

12-05-2018 12:03 PM CET | Health & Medicine

Press release from: Fact.MR

High Demand Drives Global Drug Eluting Balloon Catheter Market

In order to study the numerous upcoming trends and patterns prevailing in the Global Deodorants Market, Fact.MR has included the latest Forecast report on Drug Eluting Balloon Catheter Market to its vast database. The delivered study offers significant figures about the leading regions and applications which are functioning in the Global Drug Eluting Balloon Catheter Market Future Movements by 2022, along with their market production, consumption, revenue, upcoming industry trends and forecasted market share details. Further, the accomplished market research report also anticipates that the concerned market would grow at a constructive CAGR until 2022.

Request for Sample of this Global Market Research Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=146

Drug eluting balloon catheter is an advanced medical device which has shown remarkable efficiency in carrying out various peripheral artery and cardiovascular procedures. A large number of companies are now shifting towards manufacturing of drug eluting balloon catheters as they are proving to be more efficient as compared to stenting or balloon angioplasty. In addition, drug eluting balloon catheter can also help in treating patients who do not benefit from percutaneous coronary intervention (PCI). Factors as such are expected to favour the global drug eluting balloon catheter market in the near future. Increasing number of patients with cardiovascular ailments and surging rate of cardiology intervention procedures is driving the demand for drug eluting balloon catheter.

Manufacturers are also trying to develop low-cost devices, which will further boost its adoption over the next couple of years. As per the latest report publish by Fact.MR, the global drug eluting balloon catheter market is poised to grow reflect a staggering CAGR of 18.3% during the forecast period 2018 and 2022. At the same time, improved reimbursement support, increasing healthcare expenditure and growing geriatric population are some of the other additional factors likely to influence the growth of the market.

Drug-eluting balloon (DEB), also known as drug-coated balloon (DCB) is one of the newest medical devices under the catheter segment.  Drug-eluting balloon catheter is used in undertaking peripheral artery procedures, particularly to reduce the rate of restenosis. A drug-eluting balloon catheter is inserted into a narrowed, unhealthy coronary or peripheral artery that slowly releases a drug to restrict further cell proliferation.

Request Global Market Report with TOC Here - https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market

By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.

By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.

Competition Tracking

Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.

Europe is currently the largest market for drug eluting balloon catheter and is expected to continue its dominance throughout the assessment period. The market in the region is set to reflect a robust CAGR of 20.5% during the assessment period. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) will reflect the fastest CAGR and gain 452 BPS between 2017 and 2022.

To Buy Global Market Research Report, Go with this Link - https://www.factmr.com/checkout/146/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400, Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release High Demand Drives Global Drug Eluting Balloon Catheter Market Progress through 2017-2022 | Key Players are Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corpora here

News-ID: 1418748 • Views:

More Releases from Fact.MR

Premium Beauty and Personal Care Products Market Anticipates US$ 780.16 Billion Valuation by 2032, Driven by 4.62% CAGR
Premium Beauty and Personal Care Products Market Anticipates US$ 780.16 Billion …
The Premium Beauty and Personal Care Products Market was valued at US$ 474.7 billion in FY 2021. It is projected to increase at a 4.0% annual pace in 2022 and close at US$ 496.63 billion. Moreover, growth is predicted to pick up speed at an astounding 4.62% CAGR during the evaluation period of 2022-2032 and reach US$ 780.16 billion. With increased attention being paid to preventative healthcare in the aftermath
Automatic Pet Feeder Market To Witness Exponential Growth, Expected to Hit US$ 1.36 Billion by 2032 at 9.6% CAGR
Automatic Pet Feeder Market To Witness Exponential Growth, Expected to Hit US$ 1 …
The market for automatic pet feeders is expected to grow at a strong rate of 9.6% CAGR to reach US$ 1.36 billion by the end of 2032, from its estimated value of US$ 540.8 million in 2022. By the end of 2021, sales of automatic pet feeders with capacities greater than five liters represented about 45% of the worldwide market for automatic pet feeders. Download a Sample Copy Of Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5963 Pet owners
Tomato Powder Market Is Estimated To Reach US$ 2.3 Billion By The End Of 2033: Fact.MR Report
Tomato Powder Market Is Estimated To Reach US$ 2.3 Billion By The End Of 2033: F …
In 2023, the global market for tomato powder reached a valuation of US$ 1.6 billion. Projections indicate that by the close of 2033, sales of tomato powder on a global scale are expected to climb to US$ 2.3 billion, marking a compound annual growth rate (CAGR) of 3.7% from 2023 to 2033. The Tomato Powder Industry sales study offers a comprehensive analysis on diverse features including production capacities, Tomato Powder demand,
Portable Video Game Consoles Market Is Projected To Reach US$ 27 Billion By 2033: Fact.MR Report
Portable Video Game Consoles Market Is Projected To Reach US$ 27 Billion By 2033 …
The forecast indicates a steady rise in global demand for portable video game consoles, projecting a Compound Annual Growth Rate (CAGR) of 6% from 2023 to 2033. Presently, the market for portable video game consoles stands at a valuation of US$ 15 billion globally. This figure is poised to ascend to US$ 27 billion by the conclusion of 2033. The Portable Video Game Consoles Industry sales study offers a comprehensive analysis

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug